Scioderm
Develops topical products for the treatment of chronic skin diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD1.3b (Public information from Aug 2015)
Durham North Carolina (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $1.0m | Debt | |
$16.0m | Series A | ||
$20.0m | Series B | ||
$847m Valuation: $847m | Acquisition | ||
| Total Funding | AUD55.6m | ||
Related Content
Recent News about Scioderm
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.